3-Methyl-2-oxovaleric acid,99.81%

产品编号:Bellancom-113063| CAS NO:1460-34-0| 分子式:C6H10O3| 分子量:130.14

3-Methyl-2-oxovaleric acid 是一种神经毒素,一种酸性原和一种代谢毒素,它是由支链氨基酸不完整分解产生的异常的代谢物。

本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用,

货号 包装 价格 库存与货期 购买量 操作
Bellancom-113063
800.00 杭州 北京(现货)

增值税发票√顺丰快递√订货电话:18601927057

3-Methyl-2-oxovaleric acid

产品介绍 3-Methyl-2-oxovaleric acid 是一种神经毒素,一种酸性原和一种代谢毒素,它是由支链氨基酸不完整分解产生的异常的代谢物。
生物活性

3-Methyl-2-oxovaleric acid is a neurotoxin, an acidogen, and a metabotoxin, and also an abnormal metabolite that arises from the incomplete breakdown of branched-chain amino acids.

体外研究
体内研究
体内研究
性状Solid
溶解性数据
In Vitro: 

DMSO : 130 mg/mL (998.92 mM; Need ultrasonic)

H2O : ≥ 100 mg/mL (768.40 mM)

* "≥" means soluble, but saturation unknown.

配制储备液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 7.6840 mL 38.4202 mL 76.8403 mL
5 mM 1.5368 mL 7.6840 mL 15.3681 mL
10 mM 0.7684 mL 3.8420 mL 7.6840 mL
*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month。-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。

In Vivo:

请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂:

——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
分比是指该溶剂在您配制终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶

  • 1.

    请依序添加每种溶剂: 10% DMSO    40% PEG300    5% Tween-80    45% saline

    Solubility: ≥ 2.08 mg/mL (15.98 mM); Clear solution

    此方案可获得 ≥ 2.08 mg/mL (15.98 mM,饱和度未知) 的澄清溶液。

    以 1 mL 工作液为例,取 100 μL 20.8 mg/mL 的澄清 DMSO 储备液加到 400 μL PEG300 中,混合均匀;向上述体系中加入50 μL Tween-80,混合均匀;然后继续加入 450 μL生理盐水定容至 1 mL。

    将 0.9 g 氯化钠,完全溶解于 100 mL ddH₂O 中,得到澄清透明的生理盐水溶液
  • 2.

    请依序添加每种溶剂: 10% DMSO    90% (20% SBE-β-CD in saline)

    Solubility: ≥ 2.08 mg/mL (15.98 mM); Clear solution

    此方案可获得 ≥ 2.08 mg/mL (15.98 mM,饱和度未知) 的澄清溶液。

    以 1 mL 工作液为例,取 100 μL 20.8 mg/mL 的澄清 DMSO 储备液加到 900 μL 20% 的 SBE-β-CD 生理盐水水溶液中,混合均匀。

    将 2 g 磺丁基醚 β-环糊精加入 5 mL 生理盐水中,再用生理盐水定容至 10 mL,完全溶解,澄清透明
  • 3.

    请依序添加每种溶剂: 10% DMSO    90% corn oil

    Solubility: ≥ 2.08 mg/mL (15.98 mM); Clear solution

    此方案可获得 ≥ 2.08 mg/mL (15.98 mM,饱和度未知) 的澄清溶液,此方案不适用于实验周期在半个月以上的实验。

    以 1 mL 工作液为例,取 100 μL 20.8 mg/mL 的澄清 DMSO 储备液加到 900 μL玉米油中,混合均匀。

*以上所有助溶剂都可在 西域 网站选购。
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
参考文献

相关文档

化学品安全说明书(MSDS)

下载MSDS

质检证书(COA)

相关产品


危害码 (欧洲) Xi: Irritant;
风险声明 (欧洲) R36/37/38
安全声明 (欧洲) S26-S36/37/39-S36

Section I.Chemical Product and Company Identification
Chemical Name 3-Methyl-2-oxovaleric Acid
Portland OR
Synonym
2-Keto-3-methyl-n-pentanoic Acid
Chemical Formula
CH 3 CH 2 CH(CH 3 )COCOOH
CAS Number
1460-34-0
(International)

Section II.Composition and Information on Ingredients
Chemical NameCAS Number Percent (%)TLV/PELToxicology Data
3-Methyl-2-oxovaleric AcidMin. 90.0Not available.Not available.
1460-34-0
(Tit.)

Section III.Hazards Identification
Acute Health Effects
Irritating to eyes and skin on contact. Inhalation causes irritation of the lungs and respiratory system . Inflam m ation of
the eye is characterized by redness, w atering, and itching. Skin inflam m ation is characterized by itching, scaling,
reddening, or, occasionally, blistering.
Follow safe industrial hygiene practices and always wear proper protective equipment when handling this compound.
Chronic Health EffectsCARCINOGENIC EFFECTS : Not available.
MUTAGENIC EFFECTS : Not available.
TERATOGENIC EFFECTS : Not available.
DEVELOPMENTAL TOXICITY : Not available.
Repeated or prolonged exposure to this compound is not known to aggravate existing medical conditions.

Section IV.First Aid Measures
Eye Contact
C heck for and rem ove any contact lenses. In case of contact, im m ediately flush eyes w ith plenty of w ater for at least 15
minutes. Get medical attention.
Skin Contact
In case of contact, im m ediately flush skin w ith plenty of w ater. Rem ove contam inated clothing and shoes. W ash
clothing before reuse. Thoroughly clean shoes before reuse. Get medical attention.
Inhalation
If the victim is not breathing, perform m outh-to-m outh resuscitation. Loosen tight clothing such as a collar, tie, belt or
w aistband. If breathing is difficult, oxygen can be adm inistered. Seek m edical attention if respiration problem s do not
improve.
Ingestion
IN D U C E V O M ITIN G by sticking finger in throat. Low er the head so that the vom it w ill not reenter the m outh and throat.
Loosen tight clothing such as a collar, tie, belt or w aistband. If the victim is not breathing, perform m outh-to-m outh
resuscitation. Exam ine the lips and m outh to ascertain w hether the tissues are dam aged, a possible in dication that the
toxic material was ingested; the absence of such signs, however, is not conclusive.

Section V.Fire and Explosion Data
Auto-Ignition
FlammabilityNot available.
May be combustible at high temperature.
Flash PointsFlammable Limits
Not available.
Not available.
Combustion Products
These products are toxic carbon oxides (CO, CO2 ).
Fire Hazards
Not available.
Explosion Hazards
Risks of explosion of the product in presence of mechanical impact: Not available.
Risks of explosion of the product in presence of static discharge: Not available.
Fire Fighting Media
SMALL FIRE: Use DRY chemical powder.
and InstructionsLARGE FIRE: Use water spray, fog or foam. DO NOT use water jet.
Consult with local fire authorities before attempting large scale fire-fighting operations.
Continued on Next Page
3-Methyl-2-oxovaleric Acid

Section VI.Accidental Release Measures
Spill Cleanup
Irritating material.
InstructionsU se a shovel to put the m aterial into a convenient w aste disposal container. Finish cleaning the spill by rinsing any
contam inated surfaces w ith copious am ounts of w ater. C onsult federal, state, and/or local authorities for assistance on
disposal.

Section VII.Handling and Storage
Handling and Storage
IRRITA N T. REFRIG ERA TE. K eep aw ay from heat. M ech anical exhaust required.W hen not in use, tightly seal the
container and store in a dry, cool place. Avoid excessive heat and light. Do not breathe dust.
Information
Always store away from incompatible compounds such as oxidizing agents.

Section VIII.Exposure Controls/Personal Protection
Engineering Controls
U se process enclosures, local exhaust ventilation, or other engineering controls to keep airborne levels below
recom m ended exposure lim its. If user operations generate dust, fum e or m ist, use ventilation to keep exposure to
airborne contaminants below the exposure limit.
Personal Protection
Splash goggles. Lab coat. D ust respirator. Boots. G loves. Suggested protective clothing m ight not be sufficient;
consult a specialist BEFORE handling this product. Be sure to use a MSHA/NIOSH approved respirator or equivalent.
Exposure Limits
Not available.

Section IX.Physical and Chemical Properties
Physical state @ 20°CSolubility
Solid. (White Lumps.)
Not available.
Specific GravityNot available.
Molecular WeightPartition Coefficient
130.14
Not available.
Boiling PointVapor Pressure
84°C (183.2°F) @ 18 mmHgNot applicable.
Melting PointVapor Density
42°C (107.6°F)Not available.
Refractive IndexVolatility
Not available.Not available.
Critical TemperatureOdor
Not available.Not available.
ViscosityTaste
Not available.Not available.

Section X.Stability and Reactivity Data
Stability

This material is stable if stored under proper conditions. (See Section VII for instructions)
Conditions of Instability
Avoid excessive heat and light.
Incompatibilities
Reactive with oxidizing agents.

Section XI.Toxicological Information
RTECS Number
Not available.
Routes of Exposure
Eye Contact. Ingestion. Inhalation.
Toxicity Data
Not available.
Chronic Toxic EffectsCARCINOGENIC EFFECTS : Not available.
MUTAGENIC EFFECTS : Not available.
TERATOGENIC EFFECTS : Not available.
DEVELOPMENTAL TOXICITY : Not available.
Repeated or prolonged exposure to this compound is not known to aggravate existing medical conditions.
Acute Toxic Effects
Irritating to eyes and skin on contact. Inhalation causes irritation of the lungs and respiratory system . Inflam m ation of
the eye is characterized by redness, w atering, and itching. Skin inflam m ation is characterized by itching, scaling,
reddening, or, occasionally, blistering.
Follow safe industrial hygiene practices and always wear proper protective equipment when handling this compound.
Continued on Next Page
3-Methyl-2-oxovaleric Acid

Section XII.Ecological Information
Ecotoxicity
Not available.
Environmental Fate
Not available.

Section XIII.Disposal Considerations
Waste DisposalRecycle to process, if possible. C onsult your local regional authorities. You m ay be able to dissolve or m ix m aterial w ith
a com bustible solvent and burn in a chem ical incinerator equipped w ith an afterburner and scrubber system . O bserve all
federal, state and local regulations when disposing of the substance.

Section XIV.Transport Information
DOT Classification
Not a DOT controlled material (United States).
PIN Number
Not applicable.
Proper Shipping Name
Not applicable.
Packing Group (PG)
Not applicable.
DOT Pictograms

Section XV.Other Regulatory Information and Pictograms
TSCA Chemical Inventory
T h is p r o d u c t is NOT o n t h e E P A T o x ic S u b s t a n c e s C o n t r o l A c t (T S C A ) in v e n t o r y . T h e f o llo w in g n o t ic e s a r e r e q u ir e d b y 4 0
(EPA)CFR 720.36 (C) for those products not on the inventory list:
(i) These products are supplied solely for use in research and developm ent by or under the supervision of a technically
qualified individual as defined in 40 CFR 720.0 et sec.
(ii) The health risks of these products have not been fully determ ined. A ny inform ation that is or becom es available w ill
be supplied on an MSDS sheet.
WHMIS Classification
Not available. Not available.
(Canada)
EINECS Number (EEC)
215-955-0
EEC Risk Statements
R36/37/38- Irritating to eyes, respiratory system and skin.
Japanese Regulatory Data
ENCS No. (2)-1503

Section XVI.
Version 1.0
Validated on 3/1/2007.


SECTION 16 - ADDITIONAL INFORMATION
N/A

服务热线

13911702513
18601927057

微信客服